mRNA |
Parthenolide |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.09 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.09 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.078 |
0.09 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.09 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.09 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.049 |
0.09 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |